Charité and Samsung Comprehensive Cancer Center partner to advance cancer medicine

FHS
July 31, 2023
11:59 pm

Charité – Universitätsmedizin Berlin and the Samsung Comprehensive Cancer Center in Seoul have signed a memorandum of understanding.

First-Ever Biologic Approved for COPD

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An

September 28, 2024

Psychedelic Research Bulletin: January 2024 – Psychedelic Alpha

This January we were treated to a mix of novel psychedelic trials and an unusually large amount of re-analyses of earlier studies. Ibogaine was researched

February 13, 2024

Myricx Bio signs licence deal for WuXi Biologics’ antibody

Share this article Myricx plans to conduct preclinical as well as clinical development of the newly developed ADC for solid tumours. Credit: Gorodenkoff / Shutterstock.com.

November 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.